Downloads: 114 | Views: 399
Research Paper | Immunology | Albania | Volume 6 Issue 4, April 2017 | Popularity: 6.8 / 10
CD4+ Cell Count in the HIV/AIDS-infected People with Pulmonary Complications
Matilda Gjergji, Jul Bushati, Arjan Harxhi, Dhimiter Kraja
Abstract: Pulmonary complications in HIV/AIDS patients. Introduction Pulmonary complications are very common during the course of Acquired Immunodeficiency Syndrome. (AIDS) Aim of the studyThe main study goal is to assess the patterns of respiratory complications in the HIV/AIDS patients Materials and methodsIn the study are enrolled 77 (83.1 %male HIV/AIDS) patients with pulmonary complications, with the mean age of the subjects was 46.410.2, , and known as HIV seropositive patients from 5.1 2.4. years. Data are elaborated by SPSS17 Results By occupational, 29 (37.7 %) were unemployed, 22 (28.6 %), employed, 5 (6.5 %), farmeres, 7 (9.1 %) office-beares, 14 (18.2 %). the others, regard to the count of CD4 cellules, 6 (7.8 %) from 300-399 cel/ml, 15 (19.5 %) with 200-300 cel/ml, 28 (36.4 %) patients from 100-199 cel/ml, and 28 (36.4 %) <100cel/ml. In all of the patients (77) with HIV/AIDS are found 84 pulmonary manifestations, respectively bacterial pneumonia (first episode) in 12 (14.3 %) cases, recurent bacterial pneumonia-9 (10.6 %), pneumocystis carinii pneumonia (PCP) 33 (39, 3 %) cases, tuberculosis 27 (32.2 %), , divided in 23 (27.4 %) -cases as pulmonary tuberculosis and 4 (4.8 %) as generalised tuberculosis. Kaposy Syndrome- 2 (2.4 %), COPD -1 (1.2 %). cases. In the end of the study september 2015, 13 patients died, 12 of them had CD4 count level lower than CD4<199/ml. We found a positive correlations between ages and mortality (p=.003), the pattern of pulmonary complications with CD4+ count level. P<0.0001. ConclusionsIn our study, the most common respiratory complications and with high mortality rate, are opportunistic infections from pneumocystis carinii pneumonia ( PCP) and tuberculosis ( TB). The level of CD4+ count is a useful indicator for developing respiratory infections and complications in HIV/AIDS patients.
Keywords: CD4+, HIV/AIDS, TB, PCP, COPD
Edition: Volume 6 Issue 4, April 2017
Pages: 1718 - 1723
Make Sure to Disable the Pop-Up Blocker of Web Browser
Downloads: 313 | Views: 493
Immunology, India, Volume 8 Issue 3, March 2019
Pages: 423 - 428Immunotherapy for Cancer
Sanjivani Pathak, Sunanda Patil
Downloads: 177 | Views: 411
Immunology, India, Volume 9 Issue 4, April 2020
Pages: 663 - 671Story of the Most Triggering Issue of the Globe: 2019 Novel Coronavirus (COVID-19)
Yerusha Nuthalapati, Vanaja Sri Doddi
Downloads: 150 | Views: 459
Immunology, United States of America, Volume 6 Issue 10, October 2017
Pages: 24 - 30Research Proposal to See if Possible HCV Epitopes Can be Used to Make a Recombinant Vaccine
Jonas Tyler Doran
Downloads: 147 | Views: 347
Immunology, India, Volume 9 Issue 4, April 2020
Pages: 481 - 486A Study of the Discard Rate of Blood and Blood Products and their Management at Tertiary Care Centre
Dr. Neha Singh
Downloads: 144 | Views: 344
Immunology, Egypt, Volume 7 Issue 6, June 2018
Pages: 66 - 72Comparative Immunological Study between the Efficacy of Bivalent Inactivated H5N1-ND and Baculovirus Expressed H5N1-ND Inactivated Vaccine (BEST) in Broiler Chickens
Raheel I.A.R., Abed A.H., Hassan K.E., Orabi A.